Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Generic drugs now make up more than 88% of all prescriptions filled in pharmacies in the United States and have provided nearly $1.7 trillion in health care savings in the past decade.1 Yet tensions still persist between brand-name drugs and generics. Fifty years ago, pharmaceutical companies hurled the word generic as an insult—a reference to often unauthorized copies made by small manufacturers with questionable assurances of product utility. Yet the growth of this new industry was already under way, spurred on by waves of patent expirations, Congressional inquiries, and increasing interests of purchasers in less expensive versions of essential medications.2(pp1-136)
Sharfstein JM, Greene J. Promise and Peril for Generic Drugs. JAMA Intern Med. 2016;176(6):733-734. doi:10.1001/jamainternmed.2016.1720